Taher Abbasi

Title: Taher Abbasi: Innovator in Hematological Malignancy Treatment

Introduction

Taher Abbasi is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of hematological malignancies. His innovative approach combines plant-based supplements with antineoplastic compounds, showcasing his commitment to advancing therapeutic options for patients.

Latest Patents

Taher Abbasi holds a patent for the "Use of scientifically matched plant supplements combined with antineoplastic compounds for the treatment of hematological malignancies." This patent focuses on combination therapy for conditions such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The disclosed combination includes a therapeutically effective amount of sulforaphane, resveratrol, and curcumin, along with hypomethylating agents like azacitidine and decitabine. This innovative combination aims to enhance treatment efficacy while reducing resistance to these agents.

Career Highlights

Throughout his career, Abbasi has worked with various companies, including Brio Ventures and Cannafamily A.S. His experience in these organizations has contributed to his expertise in developing novel therapeutic strategies. He has demonstrated a strong commitment to research and innovation in the medical field.

Collaborations

Taher Abbasi has collaborated with notable professionals in his field, including Tomas Stopka and Shahabuddin Usmani. These collaborations have likely enriched his research and contributed to the development of his innovative therapies.

Conclusion

Taher Abbasi is a pioneering inventor whose work in combination therapies for hematological malignancies has the potential to transform treatment approaches. His dedication to integrating plant-based compounds with traditional therapies highlights the importance of innovation in medicine.